Summary
A new drug called Veoza is now available on the NHS in England to help women with menopausal hot flushes and night sweats who cannot use hormone replacement therapy (HRT). This non-hormonal pill offers an alternative treatment by blocking nerve pathways in the brain. It's expected to benefit around 500,000 women who have limited options due to underlying health conditions.
Key Facts
- Veoza is a daily pill used for treating hot flushes and night sweats during menopause.
- It is available on the NHS in England for women who cannot use HRT.
- The drug targets nerve pathways in the brain to reduce symptoms.
- Around 500,000 women could benefit from this treatment.
- Both England's healthcare guidance body NICE and NHS England support its use.
- Veoza is not suitable for women with breast cancer or liver disease.
- The drug was approved in 2023 and is considered cost-effective by NICE.
- Hormone replacement therapy remains the first choice for most women.
